Sex Hormones Associate With Amyotrophic Lateral Sclerosis Risk and Survival
Amyotrophic lateral sclerosis (ALS) risk differs by sex and age, implicating sex hormones as potential modifiers. This study examined plasma levels of biologically active sex hormones and their association with ALS odds and survival in cases (females n = 131, males n = 189) and controls (females n = 138, males n = 150) from the University of Michigan Pranger ALS Clinic. Higher 11-ketotestosterone levels were associated with increased ALS odds. In females, higher estrone, androstenedione, and 11-hydroxyandrostenedione were associated with increased ALS odds, while elevated estrone and estradiol predicted shorter survival. These findings highlight the potential significance of sex hormones in ALS.
Authors
- Dae‐Gyu Jang (ORCID: https://orcid.org/0009-0009-7966-1322)
- David G. Stouffer (ORCID: https://orcid.org/0009-0008-9453-8819)
- Benjamin J. Murdock (ORCID: https://orcid.org/0000-0002-3543-4007)
- Richard Joseph Auchus (ORCID: https://orcid.org/0000-0001-6815-6181)
- Stephen A. Goutman (ORCID: https://orcid.org/0000-0001-8780-6637)
- Jihyun Park (ORCID: https://orcid.org/0000-0003-1038-2586)
Institutions
- University of Michigan (US)
- Veterans Health Administration (US)
- Japan Center for Michigan Universities (JP)
- Michigan Medicine (US)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1002/acn3.70281
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- National Institutes of Health
- Centers for Disease Control and Prevention
- Agency for Toxic Substances and Disease Registry